x

Search for a clinical trial

* (*) mandatory field

A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcoma (Phase II) - FR

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Morphotek, inc.
  • Website
    • Phase : II
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institut Gustave Roussy
  • CLCC Institut Gustave Roussy
  • 114 rue Edouard Vaillant
  • 94805 VILLEJUIF CEDEX
  • FRANCE
  • More information
  • Phone  : -
  • Fax  : -
  • Website
Last update: January 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.